Similar articles

• Renal targeting of captopril selectively enhances the intrarenal over the systemic effects of ACE inhibition in rats.

  Haverdings RF, Haas M, Navis G, Van Loenen-Weemaes AM, Meijer DK, De Zeeuw D, Moolenaar F. Haverdings RF, et al. Br J Pharmacol. 2002 Aug;136(8):1107-16. doi: 10.1038/sj.bjp.0704814. Br J Pharmacol. 2002. Retraction in: Br J Pharmacol. 2003 Feb;138(4):531. doi: 10.1038/sj.bjp.0705183. PMID: 12163343 Free PMC article. Retracted.
• Effect of captopril treatment on recuperation from ischemia/reperfusion-induced acute renal injury.

  Efrati S, Berman S, Hamad RA, Siman-Tov Y, Ilgiyaev E, Maslyakov I, Weissgarten J. Efrati S, et al. Nephrol Dial Transplant. 2012 Jan;27(1):136-45. doi: 10.1093/ndt/gfr256. Epub 2011 Jun 16. Nephrol Dial Transplant. 2012. PMID: 21680852
• Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension.

  Racasan S, Hahnel B, van der Giezen DM, Blezer EL, Goldschmeding R, Braam B, Kriz W, Koomans HA, Joles JA. Racasan S, et al. Kidney Int. 2004 Feb;65(2):575-81. doi: 10.1111/j.1523-1755.2004.00410.x. Kidney Int. 2004. PMID: 14717927
• [Effects of acute pharmacological blockade of the renin-angiotensin system on intrarenal hemodynamics in patients with systemic lupus erythematosus and systemic scleroderma].

  Bugrova OV, Kutyrina IM, Bagirova VV, Morozova EV, Gromova MM. Bugrova OV, et al. Ter Arkh. 2001;73(6):20-5. Ter Arkh. 2001. PMID: 11521515 Russian.
• Angiotensin-converting enzyme inhibition in renal disease; contrasting effects on renal function in renal artery stenosis and progressive renal injury.

  Jackson B, Johnston CI. Jackson B, et al. J Hum Hypertens. 1989 Jun;3 Suppl 1:107-15. J Hum Hypertens. 1989. PMID: 2674436 Review.